Ionis Pharmaceuticals (IONS) EPS (Diluted) Growth (3y) (2012 - 2026)
Ionis Pharmaceuticals (IONS) EPS (Diluted) Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 78.99% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 37.28% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.39% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -2.00% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 83.94% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Ionis Pharmaceuticals | 9.21 Bn | 7.29 Bn | 243.11 Mn | 13.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.63% |
| Dec 31, 2025 | 65.78% |
| Sep 30, 2025 | -34.47% |
| Jun 30, 2025 | 42.83% |
| Mar 31, 2025 | -26.23% |
| Dec 31, 2024 | -33.29% |
| Sep 30, 2024 | -17.40% |
| Jun 30, 2024 | 7.51% |
| Mar 31, 2024 | -15.42% |
| Dec 31, 2023 | 25.72% |
| Sep 30, 2023 | -80.17% |
| Jun 30, 2023 | -47.92% |
| Mar 31, 2023 | -45.17% |
| Dec 31, 2022 | 36.56% |
| Sep 30, 2022 | -56.25% |
| Jun 30, 2022 | -381.25% |
| Mar 31, 2022 | -40.00% |
| Dec 31, 2021 | 170.53% |
| Sep 30, 2021 | -162.74% |
| Jun 30, 2021 | -24.87% |